Compare Quest Diagnostics Inc (DGX) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Utilities Select Sector SPDR Fund — how do they compare? Quest Diagnostics Inc trades at $230.74 (market cap $25.48B), while Utilities Select Sector SPDR Fund trades at $41.33 (market cap $23.60B). The key difference: Quest Diagnostics Inc and Utilities Select Sector SPDR Fund are close in size by market cap, and Quest Diagnostics Inc pays a 1.49% dividend while Utilities Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Utilities Select Sector SPDR Fund for 80 Days on average.
| DGX | XLU | |
|---|---|---|
Market Cap | $25.48B | $23.60B |
Volume | 941,866 | 28,758,237 |
Sector | Health | — |
52-Week High | $247.45 | $47.73 |
52-Week Low | $173.49 | $39.25 |
Typical Hold Time | 56 Days | 80 Days |
Enterprise Value | $31.23B | — |
Dividend Yield | 1.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $227.00, down 0.64% with a bearish technical signal. The company shows strong fundamentals with three consecutive quarterly earnings beats and revenue growth from $9.9B in 2024 to $11.0B in 2025. Recent developments include positive clinical study results and a new Apple Health integration, though Medicare reimbursement cuts pose headwinds. The stock trades near support at $226 with oversold RSI readings suggesting potential for near-term bounce.
DGX presents a mixed outlook with solid execution offset by regulatory risks. The 10% upside to consensus price target of $250 offers opportunity, but Medicare payment reductions and rising debt levels require monitoring. Recent earnings momentum and strategic partnerships support growth, making DGX suitable for investors comfortable with healthcare sector volatility.
XLU trades at $41.09, down 0.15% with mixed technical signals showing a bullish moving average trend but neutral oscillators. The ETF recently hit 52-week lows amid sector-wide pressure from rising interest rates. Support levels cluster around $40-41 while resistance sits at $41-42. Recent news highlights utility stocks as oversold with potential defensive appeal during market volatility.
The outlook remains cautious given interest rate sensitivity, though current levels may offer value for defensive positioning. Key risks include further rate hikes and AI power demand uncertainty. Analyst sentiment is divided with technical indicators suggesting near-term consolidation potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
